Insomnia Familial Fatal

Fatal familial insomnia is a familial prion disease linked to a mutation of the prion protein gene. Here is the latest research on this rare genetic degenerative brain disorder.

June 21, 2020
Open Access

An astrocyte cell line that differentially propagates murine prions

The Journal of Biological Chemistry
Waqas TahirHermann M Schätzl
August 2, 2020

Identification of the prion-related protein gene (PRNT) sequences in various species of the Cervidae family

Molecular Biology Reports
In-Soon RohByung-Hoon Jeong
June 24, 2020

Diagnosis of Prion Diseases by RT-QuIC Results in Improved Surveillance

Neurology
Daniel D RhoadsBrian S Appleby
July 19, 2020

Fatal familial insomnia: A new case description with early response to immunotherapy

Journal of Neuroimmunology
E Toribio-DíazErika García Di-Ruggiero
June 23, 2020
Review
Open Access

Genetic risk factors for Creutzfeldt-Jakob disease

Neurobiology of Disease
Emma Jones, Simon Mead
August 3, 2020

Intracisternal injection of beta-amyloid seeds promotes cerebral amyloid angiopathy

Brain, Behavior, and Immunity
Qiuju YuanZhi-Xiu Lin
June 27, 2020
Open Access

Psychological factors and genetic characteristics of rural cannabis users

Annals of Agricultural and Environmental Medicine : AAEM
Milena LachowiczAnna Grzywacz
July 16, 2020
Open Access

Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2019

Communicable Diseases Intelligence
Christiane StehmannSteven J Collins
July 15, 2020

The Insomnia Plague in Fictional Macondo

The Permanente Journal
Alejandro Velásquez-TorresClaudia Talero-Gutiérrez
July 29, 2020
Preprint
Open Access

Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases

MedRxiv : the Preprint Server for Health Sciences
A. ThompsonSimon Mead
June 13, 2020
Open Access

Empathy-Related Brain Activity in Somatosensory Cortex Protects From Tactile Priming Effects: A Pilot Study

Frontiers in Human Neuroscience
Michael SchaeferJohn A Bargh
July 22, 2020

Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report

Journal of Psychiatric Practice
Rhea El KhourySami Richa
July 1, 2020
Open Access

The first isolation and molecular characterization of Mycoplasma capricolum subsp. capripneumoniae Pakistan strain: A causative agent of contagious caprine pleuropneumonia

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Faisal AhmadHanif Ur Rehman
July 9, 2020
Open Access

A novel PRNP -G131R variant associated with familial prion disease

Neurology. Genetics
Jumana T AlshaikhJames A Mastrianni
July 1, 2020
Open Access

The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status

Sleep Medicine
Li-Yu LinTing Wang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/insomnia-familial-fatal/7d23898f-65ae-439d-9642-4d72967f10cc